Avaleigh Milne

Avaleigh Milne is a highly accomplished professional with a strong academic background and extensive experience in the pharmaceutical and biotechnology industries.

She holds an MBA from Harvard Business School, an MPhil in Bioscience Enterprise from the University of Cambridge, and an A.B. in Environmental Science and Public Policy from Harvard University with a pre-med focus.

Avaleigh has held key positions at reputable organizations, including Roche, Genentech, GenapSys Inc., and Millennium Pharmaceuticals, where she has demonstrated her expertise in business development, corporate strategy, and management.

She has served as the Head of Business Development for Pharma Research and Early Development at Roche and as the Oncology Basel Site Head in the Pharma Partnering division, showcasing her leadership and strategic acumen.

Prior to her roles at Roche, Avaleigh has held various positions at Genentech, GenapSys Inc., Millennium Pharmaceuticals, Atlas Venture, Bain & Company, where she leveraged her skills in business development, corporate strategy, and consulting.

Avaleigh Milne's career progression reflects her versatility and capability in navigating the complexities of the pharmaceutical and biotechnology sectors while driving successful business outcomes.

Her educational background, coupled with her diverse professional experience, positions her as a seasoned expert in the industry, adept at leading teams, forging strategic partnerships, and contributing to organizational growth and success.